Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer
Clinical trial NCT00303992 · COMPLETED
Trial details
- NCT number
- NCT00303992
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2006-11-16
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.